Ulthera Inc
4 recall(s) on record — most severe on record: Class II.
Activity by year
- Recalls (4)
- Inspections (3)
Devices registered here (2)
- Focused Ultrasound For Tissue Heat Or Mechanical Cellular DisruptionProduct code OHV (opens in a new tab) · Class II · General, Plastic Surgery · 21 CFR 878.4590
- System, Imaging, Pulsed Echo, UltrasonicProduct code IYO (opens in a new tab) · Class II · Radiology · 21 CFR 892.1560
Recalls & enforcement
- Class IIOngoing2020-09-30The Instructions for Use (IFU) updated 03/02/2020 does not match data listed in the post-approval study.
- Class IITerminated2016-05-20Complaints reported of Radiesse (+) unable to be expelled from the syringe and/or needle.
- Class IITerminated2015-10-26The expiration date encoded in the UDI barcode on the label on the product carton and the peelable patient identification label is incorrect.
- Class IITerminated2015-10-26The expiration date encoded in the UDI barcode on the label on the product carton and the peelable patient identification label is incorrect.
FDA inspections (3)
- NAI2025-10-28No Action Indicated · Bioresearch Monitoring
- NAI2023-06-22No Action Indicated · Bioresearch Monitoring
- VAI2018-07-26Voluntary Action Indicated · Compliance: Devices; Postmarket Assurance: Devices · citations posted
Source: U.S. FDA Inspections Dashboard (opens in a new tab) (device inspection classifications, 2016–present). Data as of 2026-10-06. The dashboard profile can take several seconds to load.
Related
- All facilities operated by Merz North America, Inc.
- Merz North America, Inc. (WI)
- Merz North America, Inc. (WI)
Source: U.S. FDA via openFDA (opens in a new tab) (device registration & enforcement). Data as of 2026-10-06. Verify this facility record at FDA → (opens in a new tab)
Cite this record
RegWarden. “Ulthera Inc (FEI 1012187) — FDA facility record.” Compiled from U.S. FDA public records (openFDA; FDA Data Dashboard). Data as of 2026-10-06. https://regwarden.com/facility/1012187-ulthera-inc/
Alerts for Ulthera Inc
Watchlist alerts will email you when FDA publishes a new recall, inspection classification, or warning letter for a facility you follow. They aren't open to the public yet — leave your email and we'll tell you when they are.
Want a one-page facility brief?
A single-page summary of this facility's registration and recall history for diligence. Not selling it yet — register interest and we'll follow up.